Literature DB >> 23728737

Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey.

E G Muldoon1, G M Allison, D Gallagher, D R Snydman, C Bergin.   

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) services are not well developed in the Republic of Ireland. A national programme is being instituted to standardise care. This survey aims to assess the current use of outpatient intravenous antibiotics and to quantify the needs that physicians identify in the development of a national programme. General medical consultant physicians and clinical microbiology consultants were contacted through the Royal College of Physicians of Ireland (RCPI) from April to June 2012. Data were analysed using SPSS version 20. A total of 512 physicians were contacted, of which 55 (10.7 %) responded. The majority, 38/55 (69 %), practice general internal medicine in combination with a medical specialty, 2 (4 %) general internal medicine alone, 8 (15 %) clinical microbiology and 7 (13 %) a medical specialty alone. Of those practising a medical specialty, 12 (27 %) practice infectious diseases. Seventy-four percent reported having discharged patients with intravenous antibiotics; however, 47 % did not have a designated service available. Of those with no service, 100 % identified a need for these resources. Of those responsible for an OPAT service, 56 % had not audited their service. The most common indications were skin and soft tissue infections, osteomyelitis and respiratory tract infection. Flucloxacillin was the most commonly reported antibiotic. Eleven percent responded that they never monitor laboratory studies for patients discharged with intravenous antibiotics. While OPAT services in Ireland are not well developed, patients are being discharged with intravenous antibiotics. This survey underscores the need to develop the national programme to standardise care and ensure patients receive safe and efficient therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728737      PMCID: PMC3973129          DOI: 10.1007/s10096-013-1899-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.

Authors:  Alan D Tice; Susan J Rehm; Joseph R Dalovisio; John S Bradley; Lawrence P Martinelli; Donald R Graham; R Brooks Gainer; Mark J Kunkel; Robert W Yancey; David N Williams
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

2.  Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management.

Authors:  M Dryden; K Saeed; R Townsend; C Winnard; S Bourne; N Parker; J Coia; B Jones; W Lawson; P Wade; P Howard; S Marshall
Journal:  J Antimicrob Chemother       Date:  2012-05-23       Impact factor: 5.790

Review 3.  Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention.

Authors:  W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1996-08       Impact factor: 3.254

4.  Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey.

Authors:  Aarthi Chary; Alan D Tice; Lawrence P Martinelli; Laura A Liedtke; Melissa S Plantenga; Larry J Strausbaugh
Journal:  Clin Infect Dis       Date:  2006-10-10       Impact factor: 9.079

5.  Quality-of-life assessment in an outpatient parenteral antibiotic program.

Authors:  Alan F Goodfellow; Amy O Wai; Luciana Frighetto; Carlo A Marra; Barbara M Ferreira; M Lynn Chase; Ruth E Nicol; Carole A Leong; Sally Tomlinson; Peter J Jewesson
Journal:  Ann Pharmacother       Date:  2002-12       Impact factor: 3.154

6.  Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital.

Authors:  Paul Corwin; Les Toop; Graham McGeoch; Martin Than; Simon Wynn-Thomas; J Elisabeth Wells; Robin Dawson; Paul Abernethy; Alan Pithie; Stephen Chambers; Lynn Fletcher; Dee Richards
Journal:  BMJ       Date:  2004-12-16

7.  Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison.

Authors:  S Esposito; S Noviello; S Leone; A Tice; G Seibold; D Nathwani; F Scaglione
Journal:  Int J Antimicrob Agents       Date:  2004-11       Impact factor: 5.283

8.  Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy.

Authors:  Rajendra Sharma; William Loomis; Richard B Brown
Journal:  Am J Med Sci       Date:  2005-08       Impact factor: 2.378

9.  Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.

Authors:  V G Fowler; L L Sanders; D J Sexton; L Kong; K A Marr; A K Gopal; G Gottlieb; R S McClelland; G R Corey
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

10.  Willingness to pay to assess patient preferences for therapy in a Canadian setting.

Authors:  Carlo A Marra; Luciana Frighetto; Alan F Goodfellow; Amy O Wai; M Lynn Chase; Ruth E Nicol; Carole A Leong; Sally Tomlinson; Barbara M Ferreira; Peter J Jewesson
Journal:  BMC Health Serv Res       Date:  2005-06-07       Impact factor: 2.655

View more
  2 in total

Review 1.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

2.  Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin or Vancomycin for a Skin Infection in the Outpatient Setting.

Authors:  Thomas P Lodise; Christina Palazzolo; Kerry Reksc; Elizabeth Packnett; Mark Redell
Journal:  Open Forum Infect Dis       Date:  2019-11-04       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.